Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Medical Device, Viruxal Oral and Nasal Spray, for Treating the Symptoms of COVID-19 Via Application to the Naso- and Oropharyngeal Mucosa

NCT04357990 is registered in ClinicalTrials.gov with Kerecis Ltd. as lead sponsor.

NCT NCT04357990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04357990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Medical Device, Viruxal Oral and Nasal Spray, for Treating the Symptoms of COVID-19 Via Application to the Naso- and Oropharyngeal Mucosa
Lead sponsor
Kerecis Ltd.
Phase
Not applicable
Overall status
Completed
Start date
September 4, 2020
Completion date
October 30, 2020
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19